|
Administration, Intranasal
|
D000281 |
[Delivery of medications through the nasal mucosa.
] |
|
Administration, Intravaginal
|
D000282 |
[The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.
] |
|
Administration, Intravenous
|
D061605 |
[Delivery of substances through VENIPUNCTURE into the VEINS.
] |
|
Administration, Intravesical
|
D000283 |
[The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.
] |
|
Administration, Metronomic
|
D059250 |
[Administration of low doses of a drug or a drug combination over prolonged periods of time usually at a regular interval.
] |
|
Administration, Mucosal
|
D058956 |
[Delivery of a drug or other substance into the body through the epithelium lining of MUCOUS MEMBRANE involved with absorption and secretion.
] |
|
Administration, Ophthalmic
|
D060433 |
[Application of pharmaceutically active agents on the tissues of the EYE.
] |
|
Administration, Oral
|
D000284 |
[The giving of drugs, chemicals, or other substances by mouth.
] |
|
Administration, Rectal
|
D000285 |
[The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose.
] |
|
Administration, Sublingual
|
D000286 |
[Administration of a soluble dosage form by placement under the tongue.
] |
|
Administration, Topical
|
D000287 |
[The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
] |
|
Administrative Claims, Healthcare
|
D000067575 |
[Information relating to itemized coding of procedures and costs associated with healthcare delivery, used as a means for tracking healthcare utilization, patterns of care, and treatment outcomes.
] |
|
Administrative Personnel
|
D000288 |
[Individuals responsible for the development of policy and supervision of the execution of plans and functional operations.
] |
|
Admitting Department, Hospital
|
D000289 |
[Hospital department responsible for the flow of patients and the processing of admissions, discharges, transfers, and also most procedures to be carried out in the event of a patient's death.
] |
|
Adnexa Uteri
|
D000290 |
[Appendages of the UTERUS which include the FALLOPIAN TUBES, the OVARY, and the supporting ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).
] |
|
Adnexal Diseases
|
D000291 |
[Diseases of the uterine appendages (ADNEXA UTERI) including diseases involving the OVARY, the FALLOPIAN TUBES, and ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).
] |
|
Ado-Trastuzumab Emtansine
|
D000080044 |
[Immunotoxin that consists of humanized monoclonal anti-HER2 antibody TRASTUZUMAB covalently linked to anti-microtubule agent MAYTANSINOID DM1 for treatment of metastatic breast cancer in patients who previously received trastuzumab and a TAXANES, separately or in combination.
] |
|
Adolescent
|
D000293 |
[The period of life beginning with the appearance of secondary sex characteristics and terminating with the cessation of somatic growth. The years usually referred to as adolescence lie between 13 and 18 years of age.
, A person 13 to 18 years of age.
] |
|
Adolescent Behavior
|
D000294 |
[Any observable response or action of an adolescent.
] |
|
Adolescent Development
|
D041923 |
[The continuous sequential physiological and psychological changes during ADOLESCENCE, approximately between the age of 13 and 18.
] |
